Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NewGam in Primary Immune Thrombocytopenia
NCT01349790Phase 3Completed
- Sponsor
- Octapharma
- Start
- Oct 2011
- Primary completion
- Jul 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human normal immunoglobulin in primary immune thrombocytopenia (ITP), sponsored by Octapharma. Started Oct 2011; status: completed.
02
Drugs
human normal immunoglobulin
03
Conditions
primary immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01349790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01349790.